ABI-007 (albumin-bound paclitaxel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABI-007 (albumin-bound paclitaxel), covering 2013-12-11 to 2013-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas [Phase 3]